Imunon, Inc.
IMNN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $500 | $500 |
| % Growth | – | -100% | 0% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $500 | $500 |
| % Margin | – | – | 100% | 100% |
| R&D Expenses | $11,639 | $11,288 | $11,734 | $10,619 |
| G&A Expenses | $7,493 | $9,743 | $13,688 | $10,888 |
| SG&A Expenses | $7,493 | $9,743 | $13,688 | $10,888 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $19,132 | $21,030 | $25,422 | $21,507 |
| Operating Income | -$19,132 | -$21,030 | -$24,922 | -$21,007 |
| % Margin | – | – | -4,984.3% | -4,201.4% |
| Other Income/Exp. Net | $512 | $235 | -$12,544 | -$1,146 |
| Pre-Tax Income | -$18,620 | -$20,795 | -$37,465 | -$22,153 |
| Tax Expense | $0 | -$1,280 | -$1,567 | -$1,383 |
| Net Income | -$18,620 | -$19,515 | -$35,898 | -$20,769 |
| % Margin | – | – | -7,179.6% | -4,153.9% |
| EPS | -21.104 | -28.141 | -65.552 | -748.772 |
| % Growth | 25% | 57.1% | 91.2% | – |
| EPS Diluted | -21.104 | -28.141 | -65.552 | -748.772 |
| Weighted Avg Shares Out | 882 | 693 | 548 | 28 |
| Weighted Avg Shares Out Dil | 882 | 693 | 548 | 28 |
| Supplemental Information | – | – | – | – |
| Interest Income | $450 | $726 | $503 | $18 |
| Interest Expense | $0 | $197 | $5,029 | $570 |
| Depreciation & Amortization | $718 | $720 | $732 | $703 |
| EBITDA | -$17,902 | -$19,878 | -$31,705 | -$20,880 |
| % Margin | – | – | -6,341% | -4,176% |